| LY2886721 |
|
| (CAS 1262036-50-9) |
 |
| Description： |
LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease.
LY2886721 is a novel potent agent that is used to treat Alzheimer’s Disease in preclinical experiments. LY2886721 is under clinical study. A Safety Study of LY2886721 Multiple Doses is performing in Healthy Subjects.
|
| Product No. |
KT00527 |
| Product Name |
LY2886721 |
| Synonyms |
|
| Formal Name |
|
| CAS Number |
1262036-50-9 |
| Molecular Formula |
C18H16F2N4O2S |
| Formula Weight |
390.41 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
LY2811376
AZD4547
BIBF 1120
E-3810
NVP-BGJ398
PD173074
Ponatinib
SKLB610
|
|
